"Medical imaging is an important part of healthcare and contributes to accurate disease diagnosis and treatment, but it can also lead to patient harms, such as incidental findings, overdiagnosis, anxiety, and radiation exposure that is associated with an increased risk of cancer" lead author Dr. Rebecca Smith-Bindman, USCF professor of radiology, epidemiology, and biostatistics, and obstetrics and reproductive medicine said in a statement.
Here is the good news for us: DermDetect is 100% non-invasive - no radiation or risk of cancer!
The benefit of an expert opinion is obvious, particularly in dermoscopy where there are many exceptions to every rule and the experience of an Academic Dermatologist is invaluable.
The Full Body Imaging provides a baseline for all future exams. If you ask a radiologist what is the most important image, they will answer it is the first one! You own and control your baseline exam and you share your images with your medical professional. The power to control your imaging file is new and extremely valuable! The days of having to fill out the request and wait for weeks to gain access to your images are over with DermEngine.
The Advanced Skin Cancer Screening provides the opinion of the academic dermatologist color-coded on your ultra-high-resolution images. You share these images with your medical professional and you both benefit from the ASCS. If your ASCS images have a code RED embedded in the image, this indicates that if you were being seen by the academic dermatologist in their clinic, they would perform another medical procedure on you before they released you. This may be something as simple as cryotherapy or cream, or it may be a biopsy. Your doctor makes the decision.
The advantage to you is that studies have demonstrated that a skilled dermatologist with a dermascope is 30-40% less likely to perform an unnecessary biopsy. ASCS participants get an expert opinion first. This may reduce the "harm" of over-diagnosis. Now you have two opinions and your doctor has access to image quality that is not available in their practice.
The FBI is like a chest film (without radiation) and if they see a suspicious lesion, the ASCS is like the CT (without the radiation) and the academic dermatologist is like the radiologist. DermDetect provides the DICOM/PACS workstation for analysis, the cloud for storage, and the Dermographer to acquire images and perform the screening.
In the case of "incidental findings", let us be clear that your medical team may error on the side of caution, however, skin cancer must be treated and the earlier you treat it the better the outcomes. Smaller scars are a benefit that has value to many of us.
The average CT cost $896 and the average MRI cost $1,245 compared to FBI - $99 and ASCS $250!
DermDetect helps the participant become a better patient by helping their medical professional to provide better patient care with our advanced technology that is purchased by the participant at a lower cost because it is part of national research collaboration. Win-win-win! Melanoma loses!